triethylenemelamine has been researched along with Parkinson Disease in 1 studies
Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Olanow, CW | 1 |
| Kieburtz, K | 1 |
| Leinonen, M | 1 |
| Elmer, L | 1 |
| Giladi, N | 1 |
| Hauser, RA | 1 |
| Klepiskaya, OS | 1 |
| Kreitzman, DL | 1 |
| Lew, MF | 1 |
| Russell, DS | 1 |
| Kadosh, S | 1 |
| Litman, P | 1 |
| Friedman, H | 1 |
| Linvah, N | 1 |
| The P B Study Group, F | 1 |
1 trial available for triethylenemelamine and Parkinson Disease
| Article | Year |
|---|---|
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Delayed-Action Preparations; Double-Blind Method; Drug C | 2017 |